Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders — Stella

Home/Alzheimer Dementia (AD)/Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Dementia (AD) trials

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Belgium

UZ Leuven, Leuven, Vlaams-Brabant

Key details

Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment target

~300 participants

Started

February 2026

Primary completion

September 2029

Age range

18 Years – 90 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.